Sept. 27, 2010: Genzyme's woes

GREATER BOSTON Greater Boston

A production of  

 

Recent Episodes

Supported by:

March 25, 2013: Correction Reform Debate

March 25, 2013: Correction Reform Debate

Greater Boston

March 25, 2013: Dr. Nick Trout

March 25, 2013: Dr. Nick Trout

Greater Boston

March 25, 2013: Newtown in Boston

March 25, 2013: Newtown in Boston

Greater Boston

March 21, 2013: Mayor Tom Menino

March 21, 2013: Mayor Tom Menino

Greater Boston

March 21, 2013: Olin College

March 21, 2013: Olin College

Greater Boston

March 20, 2013: A Raisin in the Sun

March 20, 2013: A Raisin in the Sun

Greater Boston

Schedule

Friday
4/5/13 12:00 PM
WGBH World
Friday
4/5/13 6:00 PM
WGBH 44
Friday
4/5/13 7:00 PM
WGBH 2
Friday
4/5/13 11:30 PM
WGBH World
TBA TBA TBA TBA

Latest Comments


Related Content

Genzyme, the largest biotech company in the Boston-area, has been hit by hard times recently. A virus contaminated the biotech giant's Allston plant and resulted in a $175 million fine from the FDA. Now, a French drug company is interested in purchasing Genzyme. Business contributor Kris Frieswick joins Emily to gauge the impact this is having on Genzyme and biotech in Boston.

Greater Boston updates from WGBH

See a sample »

   

Masterpiece Sweepstakes 2013